Join
Live feed
·
INSIDERFilingvia Quantisnow
Arcutis Biotherapeutics Inc. logo

Officer Matsuda Masaru sold $192,415 worth of shares (8,256 units at $23.31) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 126,689 units (SEC Form 4) to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.
ARQT· Arcutis Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARQT (Arcutis Biotherapeutics Inc.) and more on Quantisnow.

Officer Matsuda Masaru sold $192,415 worth of shares (8,256 units at $23.31) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 126,689 units (SEC Form 4) to cover taxes | Quantisnow